Baker McKenzie advised Sino Biopharmaceutical Limited on the deal. Sino Biopharmaceutical Limited signed a strategic partnership agreement with Boehringer Ingelheim to bring Boehringer Ingelheim’s innovative cancer therapies...
Sino Biopharmaceutical’s Partnership with Boehringer Ingelheim
Sino Biopharmaceutical Limited’s €750 Million Convertible Bonds Offer
King & Wood Mallesons (KWM) and Tian Yuan advised Sino Biopharmaceutical Limited on its first-time issuance of €750 million zero coupon convertible bonds due 2025. Conyers...